TEL : +44 (0) 1865 854 888EMAIL : firstname.lastname@example.org
Oxford Medical Diagnostics Appoints Renfrew Group International for the Industrial Design of Breath ...
OMD completes Technology Strategy Board development grant...
Oxford Medical Diagnostics receives Smart Award...
Oxford Medical Diagnostics Receives Award of a Development Grant from the Technology Strategy Board...
View All News
Oxford Medical Diagnostics is currently developing a first generation OMD Breath AnalyserTM which applies proprietary Cavity Enhanced Absorption Spectroscopy technology to the quantitative detection of acetone in human breath. Initial applications will centre on the rapid, cost-effective, and reliable non-invasive monitoring for Type 1 diabetes.
Ian Campbell Chief Executive Officer Oxford Medical Diagnostics Centre for Innovation & Enterprise Oxford University Begbroke Science Park Sandy Lane Yarnton Oxford OX5 1PF Tel: 01865 854888 Email: email@example.com
Tel: +44 (0) 1865 854 888 - email: firstname.lastname@example.org
Oxford Medical Diagnostics Ltd, Centre for Innovation & Enterprise, Begbroke Science Park, Begbroke Hill, Woodstock Road, Begbroke, OX5 1PF
Registered in England - Registered no. 06611677 - VAT No 935 9732 82
Content Management System By Fast Floor Multimedia